Elevated doses of the coronavirus vaccine increase protection against omicron strain to 95 percent in people over the age of 50, according to the UK Health and Safety Agency.
The UKHSA reported that about six months after the second dose of any coronavirus vaccine, protection against death from omicron infection was about 60 percent in people over 50 years of age.
However, this increased to about 95 per cent two weeks after receiving the boosted dose of the vaccine.
UKHSA added that the data still show a high level of protection from hospitalization after an increased dose of the vaccine.
The efficacy against hospitalization was about 90 percent for Pfizer and dropped to 75 percent 10 to 14 weeks after reinforcement.
For the “modern”, the effectiveness against hospitalization was 90-95 percent by 9 weeks after the increased dose of the vaccine.
“The evidence is clear – the vaccine helps protect us all from the effects of Covid-19, and it offers a high level of protection against the hospitalization and death of the most vulnerable members of our society,” said Dr. Mary Ramsey, Vaccination Program Manager.